J&J AngioGuard Emboli Capture Device Purchase Portends SMART Bundle

Clinical trials of Johnson & Johnson's SMART stent for carotid revascularization procedures and AngioGuard's emboli capture device could dovetail following J&J's acquisition of the Minneapolis-based start-up, announced July 7.

More from Archive

More from Medtech Insight